{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:42:14Z","timestamp":1793900534793,"version":"4.8.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,20]],"date-time":"2022-08-20T00:00:00Z","timestamp":1660953600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670518"],"award-info":[{"award-number":["81670518"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870404"],"award-info":[{"award-number":["81870404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100648"],"award-info":[{"award-number":["82100648"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M683128"],"award-info":[{"award-number":["2020M683128"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A151501225369"],"award-info":[{"award-number":["2022A151501225369"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.metabol.2022.155294","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T21:43:36Z","timestamp":1660945416000},"page":"155294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation"],"prefix":"10.1016","volume":"136","author":[{"given":"Junzhao","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingfeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bihui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2022.155294_bb0005","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.metabol.2022.155294_bb0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.metabol.2022.155294_bb0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S2468-1253(22)00062-0","article-title":"Global multi-stakeholder endorsement of the MAFLD definition","volume":"7","author":"M\u00e9ndez-S\u00e1nchez","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155294_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.584396","article-title":"Distinct cause of death profiles of hospitalized non-alcoholic fatty liver disease: a 10 years' cross-sectional multicenter study in China","volume":"7","author":"Lin","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.metabol.2022.155294_bb0025","article-title":"Risk for hepatic and extra-hepatic outcomes in nonalcoholic fatty liver disease","author":"Hagstr\u00f6m","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2022.155294_bb0030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155294_bb0035","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","article-title":"Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?","volume":"71","author":"Younes","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.metabol.2022.155294_bb0040","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155294_bb0045","first-page":"607","article-title":"Metabolic disorders combined with noninvasive tests to screen advanced fibrosis in nonalcoholic fatty liver disease","volume":"9","author":"Shi","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.metabol.2022.155294_bb0050","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","article-title":"Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD","volume":"67","author":"Hagstr\u00f6m","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155294_bb0055","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","article-title":"Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: a multi-national cohort Study","volume":"155","author":"Vilar-Gomez","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2022.155294_bb0060","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2022.155294_bb0065","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.metabol.2022.155294_bb0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1210\/er.2018-00184","article-title":"The forgotten lipids: triglycerides, remnant cholesterol, and atherosclerotic cardiovascular disease risk","volume":"40","author":"Sandesara","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2022.155294_bb0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2468-1253(20)30213-2","article-title":"Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2022.155294_bb0080","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jhep.2021.05.003","article-title":"The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease","volume":"75","author":"Nan","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.metabol.2022.155294_bb0085","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.dld.2021.02.003","article-title":"Apolipoproteins and liver parameters optimize cardiovascular disease risk-stratification in nonalcoholic fatty liver disease","volume":"53","author":"Wu","year":"2021","journal-title":"Dig Liver Dis"},{"issue":"11","key":"10.1016\/j.metabol.2022.155294_bb0090","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13098-019-0440-z","article-title":"Insulin resistance exhibits varied metabolic abnormalities in nonalcoholic fatty liver disease, chronic hepatitis B and the combination of the two: a cross-sectional study","volume":"15","author":"Ye","year":"2019","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.metabol.2022.155294_bb0095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.metabol.2022.155294_bb0100","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211033119","article-title":"Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease","volume":"12","author":"Shao","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.metabol.2022.155294_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111283","article-title":"MR quantification of total liver fat in patients with impaired glucose tolerance and healthy subjects","volume":"9","author":"Dong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2022.155294_bb0110","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000504","article-title":"The ability of lipoprotein (a) level to predict early carotid atherosclerosis is impaired in patients with advanced liver fibrosis related to metabolic-associated fatty liver disease","volume":"13","author":"Wu","year":"2022","journal-title":"Clin Transl Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2022.155294_bb0115","first-page":"S13","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2022.155294_bb0120","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/CIRCULATIONAHA.116.022367","article-title":"Predicting the 10-year risks of atherosclerotic cardiovascular disease in Chinese population: the China-PAR project (Prediction for ASCVD risk in China)","volume":"134","author":"Yang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2022.155294_bb0125","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.metabol.2022.155294_bb0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2022.155294_bb0135","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1042\/CS20200446","article-title":"Non-alcoholic fatty liver disease: a metabolic burden promoting atherosclerosis","volume":"134","author":"Zhang","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2022.155294_bb0140","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2022.155294_bb0145","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ-linking NAFLD and insulin resistance","volume":"40","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.metabol.2022.155294_bb0150","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.tem.2021.04.008","article-title":"Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease","volume":"32","author":"Lim","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.metabol.2022.155294_bb0155","doi-asserted-by":"crossref","DOI":"10.2147\/DMSO.S186505","article-title":"Elevated free fatty acid level is associated with insulin-resistant state in nondiabetic Chinese people","volume":"12","author":"Xin","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.metabol.2022.155294_bb0160","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/joim.12719","article-title":"Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver","volume":"283","author":"Dongiovanni","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/j.metabol.2022.155294_bb0165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00125-005-0125-z","article-title":"Overproduction of large VLDL particles is driven by increased liver fat content in man","volume":"49","author":"Adiels","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2022.155294_bb0170","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1530\/EJE-20-1240","article-title":"Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study","volume":"184","author":"Juli\u00e1n","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2022.155294_bb0175","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/liv.13363","article-title":"Serum apoB levels independently predict the development of non-alcoholic fatty liver disease: a 7-year prospective study","volume":"37","author":"Wang","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.metabol.2022.155294_bb0180","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12944-019-0984-9","article-title":"Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study","volume":"18","author":"Ren","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.metabol.2022.155294_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jacc.2017.11.014","article-title":"NHLBI Working Group recommendations to reduce lipoprotein(a)-mediated risk of cardiovascular disease and aortic stenosis","volume":"71","author":"Tsimikas","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.metabol.2022.155294_bb0190","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2022.155294_bb0195","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cca.2016.07.003","article-title":"Association between lipoprotein(a) and nonalcoholic fatty liver disease among Korean adults","volume":"461","author":"Nam","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.metabol.2022.155294_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2020.07.020","article-title":"Serum lipoprotein(a) levels and insulin resistance have opposite effects on fatty liver disease","volume":"308","author":"Jung","year":"2020","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.metabol.2022.155294_bb0205","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/liv.15188","article-title":"The paradigm shift from NAFLD to MAFLD: a global primary care viewpoint","volume":"42","author":"Farahat","year":"2022","journal-title":"Liver Int"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952200172X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952200172X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:31:17Z","timestamp":1758429077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952200172X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":41,"alternative-id":["S002604952200172X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155294","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: A data-driven cluster analysis with international validation","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2022.155294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"155294"}}